← back to search

Azra Bihorac

University of Florida · US
Area of research
Nephrology · Epidemiology
Research interest
Research interests include Medicine, Acute kidney injury, Intensive care medicine, Kidney disease, Internal medicine, and Workgroup.
h-index
citations
7,735
works
26
NIH funding
primary concept
email

Recent publications

Implementing Artificial Intelligence in Critical Care Medicine: a consensus of 22
Critical Care 2025cited by 46position: lastdoi
The role of sex and gender in acute kidney injury—consensus statements from the 33rd Acute Disease Quality Initiative
Kidney International 2025cited by 23position: middledoi
Use of artificial intelligence in critical care: opportunities and obstacles
Critical Care 2024cited by 121position: middledoi
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials
Critical Care 2024cited by 72position: middledoi
Digital health and acute kidney injury: consensus report of the 27th Acute Disease Quality Initiative workgroup
Nature Reviews Nephrology 2023cited by 43position: middledoi
Moving toward a contemporary classification of drug-induced kidney disease
Critical Care 2023cited by 36position: middledoi
Performance of a Standardized Clinical Assay for Urinary C–C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury
Kidney360 2022cited by 59position: middledoi
Ideal algorithms in healthcare: Explainable, dynamic, precise, autonomous, fair, and reproducible
PLOS Digital Health 2022cited by 54position: lastdoi
Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative
Nature Reviews Nephrology 2021cited by 257position: middledoi
Characterization and Outcomes of Hospitalized Children With Coronavirus Disease 2019: A Report From a Multicenter, Viral Infection and Respiratory Illness Universal Study (Coronavirus Disease 2019) Registry
Critical Care Medicine 2021cited by 47position: middledoi
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Nature Reviews Nephrology 2020cited by 701position: middledoi
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Kidney International 2020cited by 539position: middledoi
Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study
Intensive Care Medicine 2020cited by 249position: middledoi
Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome
Journal of the American College of Cardiology 2020cited by 126position: middledoi
Publisher Correction: COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Nature Reviews Nephrology 2020cited by 25position: middledoi
Quality Improvement Goals for Acute Kidney Injury
Clinical Journal of the American Society of Nephrology 2019cited by 240position: middledoi
Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness
Cardiorenal Medicine 2019cited by 24position: middledoi
Cardiac and Vascular Surgery–Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group
Journal of the American Heart Association 2018cited by 349position: middledoi
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
Critical Care Medicine 2018cited by 292position: middledoi
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
Nature Reviews Nephrology 2017cited by 1,515position: middledoi
Recovery after Acute Kidney Injury
American Journal of Respiratory and Critical Care Medicine 2016cited by 526position: middledoi
Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment
American Journal of Kidney Diseases 2016cited by 253position: middledoi
Optimal Role of the Nephrologist in the Intensive Care Unit
Blood Purification 2016cited by 38position: middledoi
Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication
American Journal of Respiratory and Critical Care Medicine 2014cited by 505position: firstdoi
Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI
Journal of the American Society of Nephrology 2014cited by 227position: middledoi
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Critical Care 2013cited by 1,368position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John A. Kellum · University of Pittsburgh8 papers (2014–2024)Jay L. Koyner · University of Chicago7 papers (2014–2024)Lakhmir S. Chawla · San Francisco VA Medical Center6 papers (2014–2022)Marlies Ostermann · Guy's and St Thomas' NHS Foundation Trust5 papers (2018–2024)Kianoush Kashani · Guangxi Medical University4 papers (2014–2023)Benjamin Shickel · University of Florida3 papers (2022–2025)Lui G. Forni · Royal Surrey NHS Foundation Trust3 papers (2018–2020)Paul McPherson · Biomark (United States)3 papers (2019–2022)Michael Heung · San Francisco VA Medical Center3 papers (2016–2020)Eric A. J. Hoste · Ghent University Hospital3 papers (2014–2020)J. Patrick Kampf · General Atomics (United States)3 papers (2019–2022)Alexander Zarbock · University of California, San Francisco2 papers (2018–2024)Kent Doi · London School of Hygiene & Tropical Medicine2 papers (2016–2016)Leo Anthony Celi · Harvard University2 papers (2024–2025)Rajit K. Basu · Lurie Children's Hospital2 papers (2016–2016)John R. Prowle · Queen Mary University of London2 papers (2018–2020)Jorge Cerdá · St Thomas' Hospital2 papers (2016–2016) · 2 papers (2024–2025)David J. Askenazi · University of Alabama at Birmingham2 papers (2016–2016)Kathleen D. Liu · University of California San Francisco Medical Center2 papers (2016–2024)